Whitfield solution

Also used as a comparator or background therapy in 1 trial

Phase	Registry id	Dates	Indication	Sponsor	Status	Outcome
Phase 4	NCT05901961 Comparator	Jun → Sep 2023	tinea pedis	Mahidol University	Completed	No outcome recorded

Every value below carries the sentence it was read from. 2 sources stand behind the page.

Field	Value	Cited text
Known as	Whitfield solution	ClinicalTrials.gov intervention name — accepted as the source's own label NCT05901961 ↗
Known as	WFs	“compared the efficacy, safety, and cost-effectiveness of ZnO-WFs with those of Whitfield's spirit solution (WFs) alone and a zinc oxide nanoparticle solution (ZnOs).” PMID 39871011 ↗ Jan 2025
Known as	Whitfield's spirit solution	“compared the efficacy, safety, and cost-effectiveness of ZnO-WFs with those of Whitfield's spirit solution (WFs) alone and a zinc oxide nanoparticle solution (ZnOs).” PMID 39871011 ↗ Jan 2025
Route	Topical	“They will be instructed to apply 0.5 mL of the solution to the lesion twice daily for a consecutive period of 8 weeks.” NCT05901961 ↗